Botulinum toxin improves reduced dorsiflexion after Achilles tendon surgery

Knee Surgery, Sports Traumatology, Arthroscopy

Volumn 18, Issue 2, 2010, Pages 265-268

  Reuter, Iris ^a   Lorbach, Olaf ^b   Mehnert, Sabine ^a   Kaps, Manfred ^a   Engelhardt, Martin ^b  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b Andreas Bannowsky Ltd   (Germany)

Author keywords

Achilles tendon; Botulinum toxin; Dorsiflexion; Pain

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ACHILLES TENDON; ADULT; ANKLE; ARTICLE; COHORT ANALYSIS; CONVALESCENCE; FEMALE; HUMAN; INJURY; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT CHARACTERISTICS AND FUNCTIONS; MALE; MULTIMODALITY CANCER THERAPY; PHYSIOTHERAPY; PLASTER CAST; POSTOPERATIVE COMPLICATION; RUPTURE;

ACHILLES TENDON; ADULT; ANKLE JOINT; BOTULINUM TOXIN TYPE A; CASTS, SURGICAL; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; NEUROMUSCULAR AGENTS; PHYSICAL THERAPY MODALITIES; POSTOPERATIVE COMPLICATIONS; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; RUPTURE, SPONTANEOUS; YOUNG ADULT;

EID: 77951256027     PISSN: 09422056     EISSN: 14337347     Source Type: Journal    
DOI: 10.1007/s00167-009-0948-0     Document Type: Article

References (13)

1. Alfredson H, Pietilä T, Jonsson P, Lornetzon R (1998) Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med 26: 360-366.
2. Bhidayasiri R, Truong DD (2005) The expanding use of botulinum toxin. J Neurol Sci 235: 1-9.
3. Cook JL, Khan KM, Purdam C (2002) Achilles tendinopathy. Man Ther 7: 121-130.
4. DiStefano VJ, Nixon JE (1973) Rupturs of the Achilles tendon. J Sports Med 1: 34-37.
5. Fröberg A, Komi P, Ishikawa M, Movin T, Arndt A (2009) Force in the Achilles tendon during walking with ankle foot orthosis. Am J Sports Med 37: 1200-1209.
6. Kirazli Y, On AY, Kismali B, Aksit R (1998) Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke. J Phys Med Rehab 77: 510-515.
7. Kubat WD, Rekant M (2008) Botulinum use as an adjunctive in a patient with multiple flexor tendon ruptures. Hand (NY) 3: 237-239.
8. Lynch RM (2004) Achilles tendon rupture: surgical versus non-surgical treatment. Accid Emerg Nurs 12: 149-158.
9. Mancini F, Sandrini G, Moglia A, Nappi G, Paccheti C (2005) A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (BOTOX) for the treatment of spastic foot. Neurol Sci 26: 26-31.
10. Placzek R, Söhling M, Gessler M, Jerosch J (2004) Botulinum toxin in orthopaedic pain therapy. Schmerz 18: 498-505.
11. Reiter F, Danni M, Lagalla G, Ceravolo G, Provinciali L (1998) Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil 79: 532-535.
12. Richardson D, Sheean G, Werring D, Desai M, Edwards S, Greenwood R, Thompson A (2000) Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychiatry 69: 499-506.
13. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P (2009) European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 41: 13-25.